期刊文献+

甲强龙分别联合两种茶碱类药物治疗慢性阻塞性肺疾病急性加重期疗效比较 被引量:5

Methylprednisolone combined with doxofylline versus aminophylline for chronic obstructive pulmonary disease in acute exacerbation period
下载PDF
导出
摘要 目的探讨甲强龙分别联合两种茶碱类药物治疗慢性阻塞性肺疾病急性加重期的疗效。方法选择南阳医专二附院收治的慢性阻塞性肺疾病急性加重期患者100例,随机分为观察组和对照组,各50例。观察组在常规治疗基础上给予甲强龙联合多索茶碱治疗,对照组在常规治疗基础上给予甲强龙联合氨茶碱治疗。测定两组治疗前后动脉血气指标,观察不良反应情况,评定治疗效果。结果治疗后两组血气指标(pH值、PaO2、PaCO2)测定结果比较,差异无统计学意义(P〉0.05)。观察组总有效率高于对照组,不良反应发生率低于对照组,差异有统计学意义(P〈0.05)。结论甲强龙联合多索茶碱或氨茶碱均能取得较好治疗效果,但甲强龙联合多索茶碱不但疗效显著,且治疗过程中不良反应少,值得借鉴。 Objective To investigate the effect of methylprednisolone combined with doxofylline versus aminophylline in the treatment of chronic obstructive pulmonary disease in acute exacerbation period. Methods 100 patients with chronic obstructive pulmonary disease in acute exacerbation period treated at our hospital were randomly divided into an observation group and a control group, 50 cases for each group. On the basis of routine treatment, the observation group were treated with methylprednisolone and doxofylline and the control group with methylprednisolone and aminophylline. The arterial blood gas indexes were measured before and after the treatment in these two groups. The adverse reactions were observed. And the therapeutic effect was evaluated. Results There were no statistical differences in the blood gas indexes(pH, PaCO2, and PaO2) between these two groups after the treatment (P〉0.05). The total effective rate was higher and the incidence of adverse reactions was lower in the observation group than in the control group, with statistical differences (P〈0.05). Conclusions Methylprednisolone combined with doxofylline or aminophylline for chronic obstructive pulmonary disease in acute exacerbation period is effective, but methylprednisolone combined with doxofylline not only is effective but also has less adverse reactions in the treatment process, so it is worth for reference.
作者 赵岩 武晗
出处 《国际医药卫生导报》 2016年第8期1114-1117,共4页 International Medicine and Health Guidance News
关键词 慢性阻塞性肺疾病 加重期 甲强龙 多索茶碱 氨茶碱 Chronic obstructive pulmonary disease Exacerbation Methylprednisolone Doxofylline Aminophylline
  • 相关文献

参考文献7

二级参考文献53

  • 1赵双平,郭曲练,艾宇航,王瑞珂,王锷,贺民.沐舒坦对吸入性肺损伤大鼠的肺保护作用[J].中国危重病急救医学,2005,17(6):364-366. 被引量:30
  • 2芮铭安,王曹锋,陈谊,杜勤.家庭氧疗对COPD患者心理情绪及生活质量的影响[J].实用老年医学,2005,19(3):135-137. 被引量:8
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8230
  • 4王玉梅.布地奈德粉吸入剂与多索茶碱联合治疗支气管哮喘68例[J].新乡医学院学报,2007,24(3):297-299. 被引量:34
  • 5陈新谦 金有豫 汤光.新编药物学[M]15版[M].北京:人民卫生出版社,2003.583.
  • 6Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary [J] . Am J Respir Crit Care Med, 2007, 176 (6) : 532-555.
  • 7Melbye H, Halvorsen DS, Hartz I, Medbo A, Brox J, Eggen AE, Njol- stad I. Bronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly. The Tromso Study 2001 [J] . Respir Med, 2007, 101 (12) : 2541-2549.
  • 8Yao YY, Liu DM, Xu DF, Li WP. Memory and learning impairment induced by dexamethasone in senescent but not young mice [J] . Eur JPharrnocol, 2007, 574 (1) : 20-28.
  • 9Page CP. Doxofylline~ a "novofylline"[J]. Pulm Pharmacol Ther,2010,23(4) :231-234.
  • 10Akram MF, Nasiruddin M, Ahmad Z, et al. Doxofylline and theophylline: a comparative clinical study[J]. J Clin Diagn Res, 2012,6(10):1681 1684.

共引文献90

同被引文献39

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部